Jeffrey Marcus Cohen, MD, FAAD
SESSIONS
F043 New Drugs, New Rashes: An Update on Cutaneous Drug Eruptions
Mar 28, 2026
•
3:30 PM - 5:30 PM
•
Room 301
S039 Psoriasis: Modern Therapeutic Approaches
Mar 29, 2026
•
1:00 PM - 4:00 PM
•
Four Seasons 1
DISCLOSURES
Advarra – Data Safety Monitoring Board(Fees); GlaxoSmithKline Immunology – Consultant (1099 relationship)(Honoraria); Logical Images, Inc – Consultant(Honoraria); Novartis – Consultant (1099 relationship)(Fees); Sanofi – Consultant (1099 relationship)(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria);